Key references: Eosinophilic oesophagitis

Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology 2014;147(6):1238-54. https://www.ncbi.nlm.nih.gov/pubmed/25109885
Dellon ES, Sheikh A, Speck O, Woodward K, Whitlow AB, Hores JM, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology 2012;143(2):321-4 e1. https://www.ncbi.nlm.nih.gov/pubmed/22561055
Kuchen T, Straumann A, Safroneeva E, Romero Y, Bussmann C, Vavricka S, et al. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. Allergy 2014;69(9):1248-54. https://www.ncbi.nlm.nih.gov/pubmed/24894658
Moawad FJ, Cheatham JG, DeZee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment Pharmacol Ther 2013;38(7):713-20. https://www.ncbi.nlm.nih.gov/pubmed/23915046
Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG. Eosinophilic esophagitis: a clinicopathological review. Pharmacol Ther 2015;146C:12-22. https://www.ncbi.nlm.nih.gov/pubmed/25200122
Wolf WA, Jerath MR, Sperry SL, Shaheen NJ, Dellon ES. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014;12(8):1272-9. https://www.ncbi.nlm.nih.gov/pubmed/24440337